Chemokine interactome mapping enables tailored intervention in acute and chronic inflammation

Philipp von Hundelshausen, Stijn M. Agten, Veit Eckardt, Xavier Blanchet, Martin M. Schmitt, Hans Ippel, Carlos Neideck, Kiril Bidzhekov, Julian Leberzammer, Kanin Wichapong, Alexander Faussner, Maik Drechsler, Jochen Grommes, Johanna P. van Geffen, He Li, Almudena Ortega-Gomez, Remco T. A. Megens, Ronald Naumann, Ingrid Dijkgraaf, Gerry A. F. NicolaesYvonne Doering, Oliver Soehnlein, Esther Lutgens, Johan W. M. Heemskerk, Rory R. Koenen, Kevin H. Mayo, Tilman M. Hackeng, Christian Weber*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article numbereaah6650
Number of pages14
JournalScience Translational Medicine
Volume9
Issue number384
DOIs
Publication statusPublished - 5 Apr 2017

Keywords

  • NATIVE CHEMICAL LIGATION
  • INSULIN-DEGRADING ENZYME
  • GLYCOSAMINOGLYCAN BINDING
  • SIGNALING PATHWAYS
  • THROMBUS FORMATION
  • RECEPTOR CXCR4
  • ATHEROSCLEROSIS
  • DIMER
  • PLATELET-FACTOR-4
  • CELLS

Cite this

von Hundelshausen, P., Agten, S. M., Eckardt, V., Blanchet, X., Schmitt, M. M., Ippel, H., Neideck, C., Bidzhekov, K., Leberzammer, J., Wichapong, K., Faussner, A., Drechsler, M., Grommes, J., van Geffen, J. P., Li, H., Ortega-Gomez, A., Megens, R. T. A., Naumann, R., Dijkgraaf, I., ... Weber, C. (2017). Chemokine interactome mapping enables tailored intervention in acute and chronic inflammation. Science Translational Medicine, 9(384), [eaah6650]. https://doi.org/10.1126/scitranslmed.aah6650